Riskpilot← Back to searchSign inGet full accessAPEX FYSIOTERAPI AS
ASActiveOrg 999546196Rønning Østgårds Vei 3, 9180 SkjervøyPhysiotherapy activities · NACE 8695Est. 20131 employees
Revenue 2022
NOK 1,3M
+3% vs 2021
EBITDA margin
7.3%
-68% vs 2021
Equity ratio
65.7%
Financial strength
Net profit 2022
NOK 69K
-70% vs 2021
| Revenue | NOK 1,3M | +3% |
| EBITDA | NOK 98K | -68% |
| Net profit | NOK 69K | -70% |
| Total assets | NOK 479K | +1% |
| Equity | NOK 314K | +28% |
| Employees | 1 | — |
Legal name
APEX FYSIOTERAPI AS
Org number
999546196
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
17. januar 2013
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2022-12-31
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Fysioterapi og det som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Rønning Østgårds Vei 3, 9180 Skjervøy
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Revenue | 1 247 | 1 168 | 1 259 | 1 298 | 1 343 |
| Staff expenses | −791 | −824 | −603 | −596 | −713 |
| EBITDA | 193 | 88 | −73 | 301 | 98 |
| Depreciation & amort. | −0 | −0 | −5 | −5 | −5 |
| EBIT | 193 | 87 | −78 | 296 | 93 |
| Net financials | −6 | −2 | −2 | −1 | −4 |
| Profit before tax | 188 | 85 | −80 | 295 | 89 |
| Tax | 24 | 19 | −18 | 65 | 20 |
| Net profit | 164 | 66 | −62 | 230 | 69 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|
| Total assets | 166 | 226 | 137 | 475 | 479 |
| Equity | 11 | 78 | 15 | 245 | 314 |
| Long-term debt | 0 | 1 | 1 | 0 | 3 |
| Short-term debt | 154 | 148 | 121 | 230 | 162 |
| Total debt | 154 | 149 | 122 | 230 | 164 |
EBITDA margin
7.3%
This company
15.8%
Market median
-54% vs market
20182022
Equity ratio
65.7%
This company
38.2%
Market median
+72% vs market
20182022
Return on equity
22.0%
This company
18.4%
Market median
+20% vs market
20182022
Net profit margin
5.2%
This company
8.1%
Market median
-36% vs market
20182022
Asset turnover
2.81×
This company
1.12×
Market median
+151% vs market
20182022
Debt / equity
0.52×
This company
0.62×
Market median
+16% vs market
20182022
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MT Deputy Member | Deputy Member | 2013 |
BL Chief Executive Officer | Chief Executive Officer | 2013 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of APEX FYSIOTERAPI AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mihkku Tostrup Østmo | Deputy Member | 0 companies |
| Bjørn Ludvig Tostrup | Chief Executive Officer | 0 companies |